All-inclusive care protocols from $115/program
Check Eligibility- Licensed provider evaluation and assessment check
- 100% bio-ready active form (No conversion lag)
- Fast-tracked delivery from premium compounding facility
- Complete syringes and cleansing prep materials included
Subcutaneous / Intramuscular
ATP Production & Neuro Care
Why Methylcobalamin Over Cyanocobalamin?
Many over-the-counter and low-cost health platforms utilize Cyanocobalamin—a synthetic format of B12 that requires a multi-tier cellular conversion cycle inside the liver. Invigor8 utilizes compounded Methylcobalamin, the bio-identical coenzyme configuration that immediately enters the bloodstream fully optimized.
ATP Baseline
Powers the mitochondria directly to optimize physical stamina.
Neuro Protection
Supports myelin sheath repair structures and neurological clarity.
Methylation Path
Aids directly with global DNA synthesis and homocysteine conversion.
Typical Protocol Calibration
Depending on initial diagnostic biomarker results from your care provider, standard health programs map across steady system integration baselines.
| Frequency Track | Standard Volume Range | Clinical Target |
|---|---|---|
| Loading Phase (Weeks 1 – 4) | 1,000 mcg to 2,500 mcg weekly | Rapid restoration of depleted tissue and systemic reserves. |
| Maintenance Track (Ongoing) | 1,000 mcg every 1 to 2 weeks | Sustained neuro-metabolic operational efficiency stabilization. |
B12 Therapy FAQ
Why use injections instead of oral tablets?
Oral supplements must traverse the gastrointestinal tract, where absorption relies heavily on intrinsic factor levels. Injections completely bypass the gut for immediate, total systemic delivery.
When will I begin noticing systemic benefits?
Many patients note steady improvements in focus, memory clarity, and baseline physical recovery times within the initial 48 to 72 hours following treatment initialization.
Can I safely stack this with weight loss paths?
Yes. Pure Methylcobalamin protocols are routinely coordinated with GLP-1 plans to manage temporary fatigue curves associated with early-stage caloric drops.
